Find a TenderAwarded

Published 19 Mar 2021, 12:56 GMT

Official UK procurement notice

Supportive Medicines - additional products (ITU, Antibiotics & EOI medicines)Open Supportive Medicines - additional products (ITU, Antibiotics & EOI medicines)

Official notice

Authority: Department of Health & Social Care (Central government)

GoodsOpen procedureAccelerated

Sectors: Medical Devices & Pharma (33) Delivery: UK

Budget not disclosedValue not published

Awarded 11 Nov 2020

Awarded to B. Braun Medical Limited +9 more10 awards

What is being bought

Published requirement description

The Department of Health and Social Care (DHSC) has awarded multiple contracts for the supply of pharmaceutical products for a UK stockpile of end of life care medicines, intensive care unit (ICU) medicines and antibiotics. The Department of Health and Social Care are managing the procurement on behalf of Public Health England.

CPV: Pharmaceutical products

The lotProcurement structure

single lot · no lot value published

Lot #1The Department of Health and Social Care conducted an accelerated open procedure…Awarded

The Department of Health and Social Care conducted an accelerated open procedure procurement exercise under the Public Contracts Regulations 2015 (as amended) to source additional pharmaceutical products for a UK stockpile of medicines in response to Covid-19. The stockpile covers additional ITU medicines, antibiotics, and end of life care medicines. The contract period is for 11 months .

Delivery: UK · Haydock, England

33600000 Pharmaceutical products

What it takes to win
i
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more

How bids were scored

Medication Presentation: Available on Request
Shelf life at delivery: Available on Request
Licensed / unlicensed medication: Available on Request
Price: Available on Request

Procedure terms & legal framework

From the official record · publisher note attached

Procedure method: Open procedure
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Goods
Notice status: Awarded
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Competitive procedure
GPA / WTO covered: Yes (GPA)
Recurring procurement: Unspecified in notice
First published: 19 Mar 2021, 12:56 GMT
Last source update: 19 Mar 2021, 12:56 GMT
Authority reference: CM-EMI-20-C12107
FTS notice number: 2021/S 000-005626
Accelerated: The Covid-19 outbreak gave rise to an urgent need for DHSC to create a stockpile of medicines suitable for use in the Intensive Treatment Unit and End of Life facilities in order to be in a position to treat the population as required in case the Covid-19 outbreak escalates suddenly. This did not give DHSC sufficient time to comply with the standard open procedure time scales for this procurement. DHSC considers this to be a state of urgency which it has duly substantiated. Accordingly, DHSC has used the accelerated time limits permitted under the Public Contract Regulations 2015 (Regulation 27(5) for the open procedure) in respect of this procurement.
Classification (CPV): Pharmaceutical products
Delivery area: UK
Official registry OCID: ocds-h6vhtk-029d6b Find a Tender

Publisher note: The contracts are for the benefit of the Authority and NHS Bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies and the local authorities, othergovernment departments or nondepartmental public bodies charged with the delivery of healthcare or health-relatedservices in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, theNational Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers.

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 16

Awarded value Not summedeach provider’s award repeats the list or panel total

Bids received 41

Contracts signed 16latest 11 Nov 2020

Awarded to	Value	Date	Status
B. Braun Medical Limited	£1 †	—	Awarded
Fresenius Kabi Limited	£1 †	—	Awarded
Torbay Pharmaceuticals	£1 †	—	Awarded
ACCORD-UK LTD	£1 †	—	Awarded
Aguettant Ltd	£1 †	—	Awarded
Aspen Pharma Ireland Ltd	£1 †	—	Awarded
CST Pharma Ltd	£1 †	—	Awarded
BioQ Pharma B.V., a subsidiary of BioQ Pharma Incorporated	£1 †	—	Awarded
Martindale Pharma	£1 †	—	Awarded
Mercury Pharmaceuticals Limited	£1 †	—	Awarded

6 further award records carry no date or value.

Contracts

Contract 005626-2021-1 · B. Braun Medical Limited
Signed
11 Nov 2020
Value
£1
Status
active
Contract 005626-2021-10 · Fresenius Kabi Limited
Signed
11 Nov 2020
Value
£1
Status
active
Contract 005626-2021-11 · Torbay Pharmaceuticals
Signed
11 Nov 2020
Value
£1
Status
active
Contract 005626-2021-12 · ACCORD-UK LTD
Signed
11 Nov 2020
Value
£1
Status
active
Contract 005626-2021-13 · Aguettant Ltd
Signed
11 Nov 2020
Value
£1
Status
active
Contract 005626-2021-14 · Aspen Pharma Ireland Ltd
Signed
11 Nov 2020
Value
£1
Status
active
Contract 005626-2021-15 · CST Pharma Ltd
Signed
11 Nov 2020
Value
£1
Status
active
Contract 005626-2021-16 · BioQ Pharma B.V., a subsidiary of BioQ Pharma Incorporated
Signed
11 Nov 2020
Value
£1
Status
active
Contract 005626-2021-2 · Martindale Pharma
Signed
11 Nov 2020
Value
£1
Status
active
Contract 005626-2021-3 · Mercury Pharmaceuticals Limited
Signed
11 Nov 2020
Value
£1
Status
active
Contract 005626-2021-4
Signed
11 Nov 2020
Value
£1
Status
active
Contract 005626-2021-5
Signed
11 Nov 2020
Value
£1
Status
active
Contract 005626-2021-6
Signed
11 Nov 2020
Value
£1
Status
active
Contract 005626-2021-7
Signed
11 Nov 2020
Value
£1
Status
active
Contract 005626-2021-8
Signed
11 Nov 2020
Value
£1
Status
active
Contract 005626-2021-9
Signed
11 Nov 2020
Value
£1
Status
active

Bid statistics published by the authority

Bids	SME	VCSE	Valid bid range
41bids	—	—	—

Contracting authority & participating public bodies

Department of Health and Social Care

Contracting authorityCentral GovernmentMinistry or any other national or federal authority, including their regional or local subdivisionsHealth 39 Victoria Street, London, London, SW1H 0EUContact name, email

Dispute resolution & review bodies

The High CourtReview body LondonContact email

Bidders & participating suppliers

16 commercial parties on the notice

Accord-UK LtdAwarded supplier Devon, UK
Aguettant LtdAwarded supplier Bristol, UK
Aspen Pharma Ireland LimitedAwarded supplier Dublin, UK
Aventis Pharma ltd t/a SanofiAwarded supplier Reading, UK
B. Braun Medical LimitedAwarded supplier Sheffield, UK
BioQ Pharma B.V., a subsidiary of BioQ Pharma IncorporatedAwarded supplier Amsterdam, UK
CST Pharma LimitedAwarded supplier Walsal, UK
Fresenius Kabi LimitedAwarded supplier Runcorn, UK
Kent Pharma LtdAwarded supplier Heathrow, UK
Martindale PharmaAwarded supplier Brentwood, UK

Show 6 more suppliers

Mercury Pharmaceuticals LimitedAwarded supplier London, UK
Neon Healthcare LtdAwarded supplier Ware, UK
Piramal Critical care LimitedAwarded supplier Uxbridge, UK
Torbay PharmaceuticalsAwarded supplier Paignton, UK
Wockhardt UK LimitedAwarded supplier Wrexham, UK
hameln pharma ltdAwarded supplier Gloucester, UK

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.